FibroBiologics, Inc. (FBLG) AI Dilution Summary

Estimated cash was $823,359 as of 2026-10-08, rolled forward from $3,515,000 at 2026-06-30 against estimated monthly burn of $1,275,833. The active funding channel is an H.C. Wainwright ATM authorised to $7,500,000, with 294,645 shares sold since the program began through 2026-06-30; sales after 2026-06-30 are not yet reported. The most recent raise is the private placement closed 2026-10-08, which brought in $1,000,000 net.